BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 49 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $975,869 | +267.1% | 950,000 | +280.0% | 0.00% | – |
| Q4 2022 | $265,828 | -42.1% | 250,000 | -45.8% | 0.00% | – |
| Q3 2022 | $459,000 | +3.1% | 461,000 | +2.4% | 0.00% | – |
| Q2 2022 | $445,000 | -1.8% | 450,000 | 0.0% | 0.00% | – |
| Q1 2022 | $453,000 | -4.2% | 450,000 | 0.0% | 0.00% | – |
| Q4 2021 | $473,000 | -45.8% | 450,000 | -47.1% | 0.00% | – |
| Q3 2021 | $873,000 | -1.4% | 850,000 | 0.0% | 0.00% | – |
| Q2 2021 | $885,000 | +1.7% | 850,000 | 0.0% | 0.00% | – |
| Q1 2021 | $870,000 | -5.0% | 850,000 | 0.0% | 0.00% | – |
| Q4 2020 | $916,000 | +3.2% | 850,000 | 0.0% | 0.00% | – |
| Q3 2020 | $888,000 | -14.9% | 850,000 | 0.0% | 0.00% | – |
| Q2 2020 | $1,043,000 | +121.9% | 850,000 | +88.9% | 0.00% | – |
| Q1 2020 | $470,000 | -48.3% | 450,000 | -47.6% | 0.00% | – |
| Q4 2019 | $909,000 | +7.4% | 858,000 | 0.0% | 0.00% | – |
| Q3 2019 | $846,000 | -5.2% | 858,000 | 0.0% | 0.00% | – |
| Q2 2019 | $892,000 | +1.1% | 858,000 | 0.0% | 0.00% | – |
| Q1 2019 | $882,000 | +4.6% | 858,000 | +0.9% | 0.00% | – |
| Q4 2018 | $843,000 | -6.9% | 850,000 | 0.0% | 0.00% | – |
| Q3 2018 | $905,000 | – | 850,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 53,670 | $57,726,000 | 3.34% |
| SHENKMAN CAPITAL MANAGEMENT INC | 26,959,000 | $29,149,000 | 3.04% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 84,134,000 | $90,539,000 | 1.93% |
| Cheyne Capital Management (UK) LLP | 3,220,000 | $3,452,000 | 1.75% |
| PFM Health Sciences, LP | 40,300,000 | $43,210,000 | 1.52% |
| Sonora Investment Management, LLC | 6,370,000 | $6,807,000 | 0.56% |
| MACKAY SHIELDS LLC | 66,018,000 | $70,980,000 | 0.49% |
| ZAZOVE ASSOCIATES LLC | 1,500,000 | $1,608,000 | 0.20% |
| IRON Financial LLC | 275,000 | $295,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,000,000 | $3,216,000 | 0.08% |